BUZZ-Australia's Immutep soars on partnering with India's Dr. Reddy’s
Reuters
Dec 09, 2025
BUZZ-Australia's Immutep soars on partnering with India's Dr. Reddy’s
** Shares of Immutep IMM.AX rise as much as 31.4% to A$0.335, their biggest intraday pct gain since May 18, 2023** Biotech co partners with India's Dr. Reddy’s Laboratories REDY.NS for commercialization of Eftilagimod Alfa, an Oncology drug** Dr. Reddy’s receives exclusive rights to develop and commercialize the drug in all countries outside North America, Europe, Japan, and Greater China** Immutep will receive $20 million upfront, eligible for milestone payments of up to $349.5 million plus royalties on commercial sales** Shares hit highest level since May 6** YTD, IMM shares down 12.3%
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.